Barbara Birk

729 total citations
26 papers, 471 citations indexed

About

Barbara Birk is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Barbara Birk has authored 26 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pharmacology. Recurrent topics in Barbara Birk's work include Pharmacogenetics and Drug Metabolism (7 papers), Hormonal Regulation and Hypertension (7 papers) and Computational Drug Discovery Methods (5 papers). Barbara Birk is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Hormonal Regulation and Hypertension (7 papers) and Computational Drug Discovery Methods (5 papers). Barbara Birk collaborates with scholars based in Germany, United States and Italy. Barbara Birk's co-authors include Rolf W. Hartmann, Matthias Negri, Simon Lucas, Ralf Heim, Robert Landsiedel, Sandrine Marchais‐Oberwinkler, Martin Frotscher, Patricia Kruchten, Alexander Oster and Ruth Werth and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Chemical Research in Toxicology.

In The Last Decade

Barbara Birk

22 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Birk Germany 8 180 140 131 115 97 26 471
Caitlin Lynch United States 14 88 0.5× 154 1.1× 94 0.7× 25 0.2× 171 1.8× 26 464
Yanyan Hong United States 11 55 0.3× 169 1.2× 294 2.2× 71 0.6× 68 0.7× 22 470
Chinaza Egbuta United States 9 35 0.2× 161 1.1× 258 2.0× 125 1.1× 94 1.0× 10 508
Jean-François Lévesque Canada 13 93 0.5× 140 1.0× 44 0.3× 106 0.9× 84 0.9× 24 496
Ron Filler United States 8 71 0.4× 184 1.3× 101 0.8× 81 0.7× 63 0.6× 12 444
Hans-Jörg Burger Germany 10 68 0.4× 218 1.6× 52 0.4× 47 0.4× 174 1.8× 14 622
Denise G. Teotico United States 7 151 0.8× 215 1.5× 181 1.4× 36 0.3× 297 3.1× 8 560
Daniel R. Mudra United States 11 32 0.2× 217 1.6× 26 0.2× 51 0.4× 270 2.8× 18 647
David J. Porubek United States 12 64 0.4× 178 1.3× 139 1.1× 33 0.3× 201 2.1× 18 507
Anisetti Ravindernath India 11 24 0.1× 129 0.9× 205 1.6× 84 0.7× 90 0.9× 16 386

Countries citing papers authored by Barbara Birk

Since Specialization
Citations

This map shows the geographic impact of Barbara Birk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Birk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Birk more than expected).

Fields of papers citing papers by Barbara Birk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Birk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Birk. The network helps show where Barbara Birk may publish in the future.

Co-authorship network of co-authors of Barbara Birk

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Birk. A scholar is included among the top collaborators of Barbara Birk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Birk. Barbara Birk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birk, Barbara, et al.. (2025). Cross-taxa extrapolation: Is there a role for thyroid hormone conjugating liver enzymes during amphibian metamorphosis?. Regulatory Toxicology and Pharmacology. 159. 105810–105810.
2.
Landsiedel, Robert, Barbara Birk, Eric Fabian, et al.. (2024). The Use of Toxicokinetic Information for Setting Concentrations of In Vitro Toxicity Tests and for Interpreting Their Results: A Proposed Workflow. 10(1). 15–26. 2 indexed citations
3.
Haake, Volker, Franziska Maria Zickgraf, Philipp Ternes, et al.. (2024). Molecular signatures of angiogenesis inhibitors: a single-embryo untargeted metabolomics approach in zebrafish. Archives of Toxicology. 98(3). 943–956.
4.
Kolle, Susanne N., et al.. (2024). Limitations and Modifications of Skin Sensitization NAMs for Testing Inorganic Nanomaterials. Toxics. 12(8). 616–616. 3 indexed citations
5.
Birk, Barbara, Philipp Ternes, Franziska Maria Zickgraf, et al.. (2023). Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin. Archives of Toxicology. 97(11). 2903–2917. 4 indexed citations
6.
Birk, Barbara, Sebastian Hoffmann, Kostja Renko, et al.. (2023). Assessment of the Predictivity of DIO1-SK Assay to Investigate DIO1 Inhibition in Human Liver Microsomes. 9(2). 44–59. 1 indexed citations
7.
Birk, Barbara, Philipp Ternes, Volker Haake, et al.. (2023). A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity. Cell Biology and Toxicology. 39(6). 2899–2917. 3 indexed citations
8.
Zickgraf, Franziska Maria, Volker Haake, Wibke Busch, et al.. (2023). A metabolomics approach to reveal the mechanism of developmental toxicity in zebrafish embryos exposed to 6-propyl-2-thiouracil. Chemico-Biological Interactions. 382. 110565–110565. 6 indexed citations
10.
Landsiedel, Robert, et al.. (2022). The Evolution of Regulatory Toxicology: Where is the Gardener?. Alternatives to Laboratory Animals. 50(4). 255–262. 7 indexed citations
11.
Birk, Barbara, Volker Haake, Saskia Sperber, et al.. (2021). Use of in vitro metabolomics in NRK cells to help predicting nephrotoxicity and differentiating the MoA of nephrotoxicants. Toxicology Letters. 353. 43–59. 4 indexed citations
12.
Birk, Barbara, et al.. (2021). The thyroid hormone converting enzyme human deiodinase 1 is inhibited by gold ions from inorganic salts, organic substances, and by small-size nanoparticles. Chemico-Biological Interactions. 351. 109709–109709. 5 indexed citations
14.
Birk, Barbara, et al.. (2020). In Silico Models to Predict the Perturbation of Molecular Initiating Events Related to Thyroid Hormone Homeostasis. Chemical Research in Toxicology. 34(2). 396–411. 39 indexed citations
15.
Desprez, Bertrand, Barbara Birk, Bas J. Blaauboer, et al.. (2019). A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity. Toxicology in Vitro. 59. 44–50. 17 indexed citations
16.
17.
Lucas, Simon, et al.. (2009). Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 116(3-5). 121–126. 18 indexed citations
20.
Tritschler, Felix, Radovan Murín, Barbara Birk, et al.. (2007). Thrombin causes the Enrichment of Rat Brain Primary Cultures with Ependymal Cells Via Protease-Activated Receptor 1. Neurochemical Research. 32(6). 1028–1035. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026